"The U.S. Food and Drug Administration today notified Ranbaxy Laboratories, Ltd., that it is prohibited from manufacturing and distributing active pharmaceutical ingredients (APIs) from its facility in Toansa, India, for FDA-regulated drug product"...
- Patient Information:
Cardiovascular System: Hypotension
Gastrointestinal System: Nausea, vomiting, abdominal discomfort or pain.
Dermatologic System: Allergic rash.
Hematologic System: Rarely, decreased white blood cell count or bone marrow depression.
Read the Metopirone (metyrapone) Side Effects Center for a complete guide to possible side effects
Drugs affecting pituitary or adrenocortical function, including all corticosteroid therapy, must be discontinued prior to and during testing with Metopirone (metyrapone) .
The metabolism of Metopirone (metyrapone) is accelerated by phenytoin; therefore, results of the test may be inaccurate in patients taking phenytoin within two weeks before. A subnormal response may occur in patients on estrogen therapy.
Metopirone (metyrapone) inhibits the glucuronidation of acetaminophen and could possibly potentiate acetaminophen toxicity.
Read the Metopirone Drug Interactions Center for a complete guide to possible interactions
Last reviewed on RxList: 12/14/2010
This monograph has been modified to include the generic and brand name in many instances.
Additional Metopirone Information
- Metopirone Drug Interactions Center: metyrapone oral
- Metopirone Side Effects Center
- Metopirone Overview including Precautions
- Metopirone FDA Approved Prescribing Information including Dosage
Metopirone - User Reviews
Metopirone User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
Find out what women really need.